Itraconazole

The susceptibility rates of 161 strains of yeastlike fungi to azole antifungals, such as fluconazole, itraconazole and ketoconazole were 95 7%, 94 4% and 85 1% respectively.

结果，161株酵母样真菌对唑类抗真菌药氟康唑、伊曲康唑、酮康唑的敏感率分别为95.7%、94.4%、85.1%。

Conclusion Itraconazole was effective medicine to treat Onychomycosis.

伊曲康唑是治疗甲癣较理想的药物.

After 3 weeks, the obvious improvement rates of itraconazole were 88.9% for treating tinea manus and tinea pedis, 96.7% for tinea corporis and tinea cruris. The total obvious improvement rate and the eliminate rate of dermatophyte were 92.4% and 95.5%, respectively.

3周后的痊愈率和显效率分别为88.9%和96.7%，总显效率为92.4%，真菌清除率为95.5%。

Objective : To observe the effectiveness of sporanox capsules ( itraconazole ) in treating perianal moniliasis.

目的: 观察口服斯皮仁诺胶囊 ( 伊曲康唑 ) 治疗肛周念珠菌病的疗效.

CONCLUSION Itraconazole solid dispersion can significantly increase it's solubility and dissolution rate.

结论：伊曲康唑固体分散体能明显提高伊曲康唑的溶解度及体外溶出速率。

Results: The respective 90% MICs ( MIC 90) of ketoconazole, 5 flucytosine, itraconazole, amphotericin B and fluconazole against 102 isolates of Candida albicans were 0.25, 0.5, 0.5,2 and 8 μ g/ ml.

结果：酮康唑、氟胞嘧啶和伊曲康唑对102株白色念珠菌MIC较低，其MIC90分别为0.25μg/ml、0.5μg/ml和0.5μg/ml。两性霉素B和氟康唑MIC90分别为2μg/ml和8μg/ml。

Objective: To evaluate the utilization of itraconazole in the treatment of superficial candidal infections in dermatological clinic of China.

目的：评价适宜国人的伊曲康唑治疗浅表念珠菌感染的治疗方案。

Objective: To observe the curative effective of Itraconazole in curing dermatitis seborrheica.

目的：观察伊曲康唑治疗脂溢性皮炎临床疗效。

Short term itraconazole in the treatment of tinea manus ( hyperkeratosis type): comparison of two treatment regimes

伊曲康唑短程疗法治疗角化型手癣2种方案比较

Nursing of one cases of drug-induced exfoliative dermatitis caused by oral itraconazole

1例伊曲康唑口服液致药物性剥脱性皮炎患者的护理

Morphological changes of dermatophytes treated by itraconazole A case report of tinea capitis mimicking seborrheic dermatitis in a child

伊曲康唑对皮肤癣菌形态学影响研究表现为脂溢性皮炎样的儿童头癣1例

Oral Itraconazole for Superficial Dermatomycosis: A Clinical Series of 200 Patients

口服伊曲康唑治疗皮肤浅部真菌病200例临床观察

Efficacy of itraconazole pulse therapy in treatment of onychomycosis: a multicentre open study

伊曲康唑间歇冲击疗法治疗甲真菌病的多中心开放性研究

Amphotericin B and parenteral solution of Itraconazole have no obvious difference.

二性霉素B和伊曲康唑注射液在疗效上差异无显著性。

Clinical analysis of sequential therapy with itraconazole and terbinafine in the treatment for toenail onychomycosis

序贯疗法治疗甲真菌病的临床研究

In conclusion, treatment with amphotericin B and itraconazole has negligible efficacy in CNS aspergillosis.

结论:联用两性霉素B和伊曲康唑治疗CNS曲霉病无明显疗效.

Result: Candida species are resistant to terbinafine, medium susceptible to fluconazole 、 ketoconazole 、 miconazole and clotrimazole, high susceptible to nystatin 、 itraconazole 、 amphotericin B and flucytosine.

结果：检测出的念珠菌对特比萘芬耐药，对氟康唑、酮康唑、咪康唑、克霉唑中度敏感，对制霉菌素、伊曲康唑、两性霉素B、氟胞嘧啶高度敏感。

Evaluation the antimycotic activity of itraconazole in human stratum corneum with vitro fungi cultivation

应用人表皮角质层体外真菌培养法评价伊曲康唑的抗菌活性

Observation the curative effective of itraconazole in curing dermatitis seborrheica

伊曲康唑治疗脂溢性皮炎疗效评价

Drug resistance rate from high to low of the frequently used antimycotic drug for Candida mycoderma bacteria are Itraconazole, fluconazol, econazole, amphotericin in turns.

常用抗真菌药物对假丝酵母菌耐药率由高到低依次是伊曲康唑、氟康唑、益康唑，最低为两性霉素。

Conclusion injection itraconazole is an effective therapy for IPFI.

结论伊曲康唑注射液是治疗侵袭性肺部真菌感染有效的药物,临床上可作为一线用药治疗使用.

CONCLUSION: These two kinds of itraconazole capsules are bioequivalent.

结论2种伊曲康唑胶囊具有生物等效性.

Objective To evaluate the clinical efficacy and safety of intravenous itraconazole ( Sporanox) in treatment of invasive fungal infected patients with multiple organ dysfunction syndrome ( MODS).

目的观察伊曲康唑序贯疗法治疗老年多脏器功能障碍综合征（MODS）患者侵袭性肺部真菌感染的疗效。

The rate of C. albicans susceptibility to amphotericin B, fluconazole, flucytosine ( 5-FC) and itraconazole were 100%, 94.6%, 92.86% and 57.1%, respectively.

白色念珠菌对两性霉素B、氟康唑、氟胞嘧啶和伊曲康唑的敏感性分别为100%、94.6%、92.86%和57.1%。

Objective To study the security of Itraconazole ( commercial name is Sporanox) in the treatment of fungal disease under treatment dose.

目的：考察伊曲康唑（商品名斯皮仁诺）在皮肤真菌性疾病治疗剂量下的药物安全性。

Methods: using 96 well microtiter trays as testing carriers, and ten twofold serial dilutions were made. The susceptibilities of 30 dermatophyte strains isolated from clinic to itraconazole and fluconazole, two new azole antifungal drugs, were determined.

方法：用96孔酶标板做药敏试验载体，10级倍比稀释药液，测定30株皮肤癣菌临床分离株对三唑类新药伊曲康唑和氟康唑的敏感性。

Objective: To evaluate and compare the efficacy and safety of two dosages of short term itraconazole in the treatment of tinea manus ( hyperkeratosis type).

目的：评价并比较伊曲康唑2种短程疗法治疗角化型手癣的临床疗效、真菌学疗效及安全性。

The patient received oral itraconazole and 5 FC and showed favorable effect.

口服伊曲康唑和5氟胞嘧啶有明显效果。

100% of Candida albicans isolates were susceptible to 5 flucytosine and 88.3% and 75.5% were susceptible to fluconazole and itraconazole.

受试菌对氟胞嘧啶敏感率最高为100%，对氟康唑和伊曲康唑的敏感率分别为88.3%和75.5%。

Other azole antifungals such as itraconazole are substantially more expensive and do not have greater efficacy.

其他的吡咯类抗真菌药如伊曲康唑更加昂贵，且并不会有更好的效果。